1MURPHY E L,COLLIER A C’KALISH L A’et al. Highly ac-tive antiretroviral therapy decreases mortality and morbidity inpatients with advanced HIV disease [ J ]. Ann Intern Med,2001,135(1) :17-26.
2De LUCA A,ZAZZI M D E. Interplay between transmitted andacquired HIV type 1 drug resistance : reasons for a disconnect[J].J Infect Dis,2015,212(1) :5-7.
3WITTKOP L,GUNTHARD H F,de WOLF F,et al. Effect oftransmitted drug resistance on virological and immunologicalresponse to initial combination antiretroviral therapy for HIV(EuroCoord- CHAIN joint project) : a European multicohortstudy[ J] . Lancet Infect Dis;2011,11(5) :363-371.
4DRESCHER S M,von WYL V,YANG W L,et al. Treatment-naive individuals are the major source of transmitted HIV- 1drug resistance in men who have sex with men in the SwissHIV Cohort Study[ J] . Clin Infect Dis,2014,58(2) :285-294.
5Department of Health and Human Services. Guidelines for theuse of antiretroviral agents in HIV- 1 _ infected adults and ado-lescents [C/OL ]. http://.www. aidsinfo. nih. gov/Content-Files/AdultandAdolescentGL. pdf. updated April 2015.
9WENSING A M,CALVEZ V,GUNTHARD H F,et al. 2014Update of the drug resistance mutations in HIV- 1 [ J ]. TopAntivir Med,2014,22(3) :642-650.
10Stanford University HIV Drug Resistance Database: MajorHIV-1 drug resistance mutations,updated March 9,2015 [ C/OL]. http://hivdb. Stanford. edu/pages/drugSummaries. ht-ml.
4Palella FJ Jr,Delaney KM,Moorman AC,et al.Decliningmorbidity and mortality among patients with advancedhuman immunodeficiency virus infection[J].N Engl JMed,1998,338(13):853-860.
5Preston BD,Poiesz BJ,Loeb LA.Fidelity of HIV-1 reversetranscriptase[J].Science,1988,242(4882):1168-1171.
6Roberts JD,Bebenek K,Kunkel TA.The accuracy of reversetranscriptase from HIV-1[J].Science,1988,242(4882):1171-1173.
7Shafer RW,Schapiro JM.HIV-1 drug resistance mutations: anupdated framework for the second decade of HAART[J].AIDSRev,2008,10(2):67-84.
8Barbaro G,Scozzafava A,Mastrolorenzo A,et al.Highly activeantiretroviral therapy: current state of the art,new agents and theirpharmacological interactions useful for improving therapeuticoutcome[J].Curr Pharm Des,2005,11(14):1805-1843.
9Naeger LK,Margot NA,Miller MD.Increased drug susceptibilityof HIV-1 reverse transcript asemutants containing M184V andzidovudine,associated mutations: analysis of enzyme processivity,chainterminat or removal and viral replication[J].AntivirTher,2001,6(2):115-126.
10Clavel F,Hance AJ.HIV drug resistance[J].N Engl JMed,2004,350(10):1023-1035.
